Veeva Systems (VEEV) is highlighted as a crucial 'picks and shovels' provider for the drug development industry, supporting its foundational needs.

Stifel, a financial services company, has reiterated its "Buy" rating for Veeva Systems (VEEV) stock.

This article explores the factors contributing to Veeva Systems' (VEEV) resilience despite ongoing concerns about AI disruption in the industry.

Multiple articles provide analysis on various stocks, including high-growth AI companies, Visa, SoundHound AI, Western Digital, DNOW, HEICO, Spotify, TransAlta, Applied Materials, CoreWeave, Honeywell, and Illinois Tool Works, evaluating their potential as investment opportunities.

Veeva Systems experienced a decline in its stock price after market close, despite reporting better-than-expected first-quarter results for fiscal year 2027 and raising its guidance.

Veeva Systems announced that Kindeva Drug Delivery has chosen to implement Veeva Quality Cloud to streamline its quality management processes. This adoption aims to improve efficiency and compliance within Kindeva's operations.

Veeva Systems has been added to the S&P 500 index, prompting analysis on the reasons to invest in the company and potential drawbacks.

Bares Capital continues to maintain a bullish outlook on Veeva Systems Inc. (VEEV) stock, signaling ongoing confidence in its performance.

An analysis explores the factors contributing to a positive outlook for the future of Veeva Systems Inc (VEEV), a technology company.

The investment potential of Veeva Systems (VEEV) is being considered, with analysis on whether it represents a good stock to buy now.

Veeva Systems has projected a fiscal year outlook above expectations and aims for a $6 billion revenue run rate by 2030.

Veeva Systems (VEEV) stock retreated following management's disclosure of competitive losses, impacting investor sentiment.

Veeva Systems (VEEV) stock experienced a decline in trading despite the company reporting impressive financial results.

An analysis explores what distinguishes Veeva Systems as a mission-critical software provider, focusing on its essential role in various industries.

Analysts are examining the future direction of Veeva Systems following its recent product launches and the acquisition of Copli.

An analysis examines whether Veeva Systems stock is underperforming compared to the Nasdaq index.

A summary of Veeva Systems Inc.'s Q1 2027 earnings call outlines the company's financial performance and strategic insights for the quarter.

Several companies, including Descartes Systems, IDT Corporation, and Veeva Systems, have reported their Q1 earnings, with many beating analyst expectations. Other companies like Caleres, Orion Energy Systems, Toro, X-Energy, and Lululemon are previewing their upcoming Q1 or Q2 earnings.

Investors and fans of Veeva Systems stock are being advised to mark May 7 on their calendars, indicating an upcoming significant event or announcement related to the company.

Articles analyze whether Zscaler, Veeva Systems, and Limbach Holdings are good investment opportunities. They provide insights into the potential of these specific stocks for investors.

Veeva Systems (VEEV) has officially announced its acquisition of Ostro. This strategic move is expected to integrate Ostro's capabilities into Veeva's existing portfolio.

An article explores whether Veeva Systems stock has the potential to generate significant wealth for investors, analyzing its market performance and prospects.

Vermilion Energy has announced a 4% increase in its dividend, raising it to C$0.135 per share.

Veeva Systems Inc. has introduced eSource, a new solution designed to streamline the collection and management of clinical trial data, aiming to improve efficiency in research.

Veeva Systems (VEEV) experienced a decline in its stock price due to a broader sector rotation in the market.

Veeva Systems (VEEV) is facing scrutiny due to concerns over competitive dynamics within its market. These competitive pressures are reportedly weighing on the company's performance and future outlook.

Veeva Systems Inc. (VEEV) has announced the acquisition of Copli and the simultaneous launch of its new product, Veeva Falcon MLR, expanding its offerings in the market.

Veeva Systems has announced the acquisition of Copli, a move expected to expand its offerings in the life sciences technology sector.

Veeva Systems discussed its first-quarter financial results during its earnings call, providing insights into its performance and outlook.

Veeva Systems has introduced Falcon, an innovative agentic platform specifically designed to enhance drug development processes within the life sciences industry. This new offering aims to streamline and improve efficiency in pharmaceutical research.

Veeva Systems stock is being recommended as a buy in anticipation of its upcoming inclusion in the S&P 500 index, scheduled for May 7, which is expected to boost its market appeal.

Veeva Systems Inc. (VEEV) has been highlighted as one of the most oversold healthcare stocks, suggesting a potential investment opportunity.

Veeva Systems (VEEV) stock experienced a decline driven by investor concerns over increased competition in its market.

Veeva Systems has announced the acquisition of Ostro, a brand engagement platform, for a sum of $100 million, expanding its offerings in the life sciences sector.

Veeva Systems has announced a strategic projection for its CRM segment, expecting it to contribute 10% of total revenue by 2030, driven by increasing momentum in artificial intelligence applications.

The Artisan Mid Cap Fund has sold its position in Veeva Systems (VEEV), with reasons for the divestment being analyzed.

Veeva Systems received an upgrade from Morgan Stanley, with analysts suggesting that the recent stock selloff reflects broader risks within the CRM sector.